Elite Pharmaceuticals, Inc. (ELTP)

Elite Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 11, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	556	465	157	29	35	62
Market Cap Growth	195.83%	195.83%	434.24%	-16.81%	-42.59%	1.75%
Enterprise Value	556	468	159	27	31	61
Last Close Price	0.52	0.43	0.15	0.03	0.03	0.06
PE Ratio	-	-	7.81	8.26	3.97	12.10
PS Ratio	6.62	5.53	2.77	0.86	1.10	2.42
PB Ratio	10.39	8.68	2.73	1.01	1.40	3.81
P/TBV Ratio	10.45	8.73	2.74	1.03	1.43	3.92
P/FCF Ratio	95.36	79.70	-	-	5.88	21.50
P/OCF Ratio	74.57	62.33	-	8.81	5.43	19.27
EV/Sales Ratio	6.61	5.56	2.81	0.80	0.96	2.40
EV/EBITDA Ratio	23.61	20.43	13.09	5.25	4.94	17.86
EV/EBIT Ratio	26.20	22.05	14.75	6.92	6.11	28.90
EV/FCF Ratio	95.29	80.19	-	-	5.15	21.24
Debt / Equity Ratio	0.20	0.20	0.20	0.13	0.11	0.15
Debt / EBITDA Ratio	0.46	0.46	0.95	0.73	0.43	0.66
Debt / FCF Ratio	1.87	1.87	-	-	0.46	0.83
Asset Turnover	0.93	0.93	0.91	0.90	1.05	0.99
Inventory Turnover	3.01	3.01	2.69	2.16	2.97	2.95
Quick Ratio	3.42	3.42	2.04	1.40	1.73	1.15
Current Ratio	4.88	4.88	3.07	2.75	2.82	2.10
Return on Equity (ROE)	-7.77%	-7.77%	46.47%	13.15%	43.01%	37.96%
Return on Assets (ROA)	14.72%	14.72%	10.83%	6.52%	10.33%	5.14%
Return on Capital (ROIC)	19.82%	19.82%	13.20%	8.15%	13.62%	7.92%
Return on Capital Employed (ROCE)	25.10%	25.10%	15.30%	12.00%	17.80%	10.30%
Earnings Yield	-0.78%	-0.93%	12.80%	12.11%	25.18%	8.27%
FCF Yield	1.05%	1.26%	-2.57%	-8.15%	17.00%	4.65%
Buyback Yield / Dilution	-4.40%	-4.40%	-1.02%	-0.23%	-7.17%	5.06%

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.